Stem Cell Therapeutic and Research Reauthorization Act of 2026
Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Email me when S 4109 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 4109. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill renews the federal program that supports stem‑cell therapies, keeping the C.W. Bill Young Cell Transplantation Program funded at $31,009,000 now and $33,009,000 each year from 2027 to 2031. It also pushes back the deadline for the cord‑blood inventory requirement from 2026 to 2031. The measure is intended to preserve research and treatment options for patients who rely on stem‑cell transplants.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 4109
3 free questions a day, no accountHistory
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093)
- Introduced in Senate
Sponsors
- Sen. Reed, Jack [D-RI] (D) · sponsor
- Sen. Lankford, James [R-OK] (R)
- Sen. Scott, Tim [R-SC] (R)
- Sen. Smith, Tina [D-MN] (D)
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 4109 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 4109 freeOr ask your AI assistant about S 4109 directly:
Add to Claude, ChatGPT or Cursor